Hematopoietic growth factors in oncology : basic science and clinical therapeutics /

Saved in:
Bibliographic Details
Imprint:Totowa, N.J. : Humana Press, c2004.
Description:x, 477 p. : ill. ; 26 cm.
Language:English
Series:Cancer drug discovery and development
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/5169705
Hidden Bibliographic Details
Other authors / contributors:Morstyn, George, 1950-
Foote, MaryAnn.
Lieschke, Graham J.
ISBN:1588293025 (alk. paper)
Notes:Includes bibliographical references and index.

MARC

LEADER 00000pam a22000004a 4500
001 5169705
003 ICU
005 20050408160400.0
008 030801s2004 njua b 001 0 eng
010 |a  2003017466 
020 |a 1588293025 (alk. paper) 
040 |a DNLM/DLC  |c DLC  |d DLC  |d UtOrBLW  |d UtOrBLW  |d OrLoB-B 
042 |a pcc 
050 0 0 |a RC271.H43  |b H45 2004 
060 1 0 |a WH 140  |b H487383 2004 
082 0 0 |a 616.99/4061  |2 22 
245 0 0 |a Hematopoietic growth factors in oncology :  |b basic science and clinical therapeutics /  |c edited by George Morstyn, Maryann Foote, Graham J. Lieschke. 
260 |a Totowa, N.J. :  |b Humana Press,  |c c2004. 
300 |a x, 477 p. :  |b ill. ;  |c 26 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
440 0 |a Cancer drug discovery and development 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t Introduction to Hematopoietic Growth Factors: A General Overview /  |r George Morstyn and MaryAnn Foote --  |g 2.  |t Animal Models of Hematopoietic Growth Factor Perturbations in Physiology and Pathology /  |r Graham J. Lieschke --  |g 3.  |t The Jak/Stat Pathway of Cytokine Signaling /  |r Ben A. Croker and Nicos A. Nicola --  |g 4.  |t Small-Molecule and Peptide Agonists: A Literature Review /  |r Ellen G. Laber and C. Glenn Begley --  |g 5.  |t Granulocyte Colony-Stimulating Factor /  |r Graham Molineux --  |g 6.  |t Erythropoietic Factors: Clinical Pharmacology and Pharmacokinetics /  |r Steven Elliott, Anne C. Heatherington and MaryAnn Foote --  |g 7.  |t Thrombopoietin Factors /  |r David J. Kuter --  |g 8.  |t Stem Cell Factor and Its Receptor, c-Kit /  |r Keith E. Langley --  |g 9.  |t Hematopoietic Growth Factors: Preclinical Studies of Myeloid and Immune Reconstitution /  |r Ann M. Farese and Thomas J. MacVittie --  |g 10.  |t Commentary on the ASCO and ESMO Evidence-Based Clinical Practice Guidelines for the Use of Hematopoietic Colony-Stimulating Factors /  |r Richard M. Fox --  |g 11.  |t Neutropenia and the Problem of Fever and Infection in Patients With Cancer /  |r David C. Dale --  |g 12.  |t Thrombocytopenia and Platelet Transfusions in Patients With Cancer /  |r Lawrence T. Goodnough --  |g 13.  |t Hematopoietic Growth Factors in Lung Cancer /  |r Johan F. Vansteenkiste and Christophe A. Dooms --  |g 14.  |t Role of Hematopoietic Growth Factors As Adjuncts to the Treatment of Hodgkin's and Non-Hodgkin's Lymphomas /  |r Marcie R. Tomblyn and Jane N. Winter --  |g 15.  |t Use of Granulocyte Growth Factors in Breast Cancer /  |r Eric D. Mininberg and Frankie Ann Holmes --  |g 16.  |t Role of Cytokines in the Management of Chronic Lymphocytic Leukemia /  |r Carol Ann Long --  |g 17.  |t Hematopoietic Growth Factor Therapy for Myelodysplastic Syndromes and Aplastic Anemia /  |r Jason Gotlib and Peter L. Greenberg --  |g 18.  |t Use of Hematopoietic Growth Factors in AIDS-Related Malignancies /  |r MaryAnn Foote --  |g 19.  |t The Safety of Hematopoietic Growth Factors /  |r Roy E. Smith and Barbara C. Good --  |g 20.  |t Long-Term Safety of Filgrastim in Chronic Neutropenias /  |r Karl Welte --  |g 21.  |t Economics of Hematopoietic Growth Factors /  |r Gary H. Lyman and Nicole M. Kuderer --  |g 22.  |t Potential for Hematopoietic Growth Factor Antagonists in Oncology /  |r Hayley S. Ramshaw, Timothy R. Hercus, Ian N. Olver and Angel F. Lopez. 
650 0 |a Hematopoietic growth factors  |x Therapeutic use. 
650 0 |a Hematopoietic growth factors  |x Mechanism of action. 
650 0 |a Cancer  |x Chemotherapy.  |0 http://id.loc.gov/authorities/subjects/sh85019497 
650 1 2 |a Hematopoietic Cell Growth Factors  |x therapeutic use. 
650 2 2 |a Hematopoietic Cell Growth Factors  |x pharmacology. 
650 2 2 |a Neoplasms  |x therapy. 
650 7 |a Cancer  |x Chemotherapy.  |2 fast  |0 http://id.worldcat.org/fast/fst00845327 
650 7 |a Hematopoietic growth factors  |x Therapeutic use.  |2 fast  |0 http://id.worldcat.org/fast/fst00954929 
700 1 |a Morstyn, George,  |d 1950-  |0 http://id.loc.gov/authorities/names/n88097257  |1 http://viaf.org/viaf/114964825 
700 1 |a Foote, MaryAnn.  |0 http://id.loc.gov/authorities/names/n87103062  |1 http://viaf.org/viaf/26108764 
700 1 |a Lieschke, Graham J.  |0 http://id.loc.gov/authorities/names/n2003129667  |1 http://viaf.org/viaf/31381628 
901 |a ToCBNA 
903 |a HeVa 
903 |a Hathi 
035 |a (OCoLC)52814665 
929 |a cat 
999 f f |i 418c1bcf-68b1-5229-bb41-fc178a887609  |s 0bcf7c85-9f6e-5156-b5a1-9f16be2641f4 
928 |t Library of Congress classification  |a RC271.H43 H45 2004  |l JCL  |c JCL-Sci  |i 4813583 
927 |t Library of Congress classification  |a RC271.H43 H45 2004  |l JCL  |c JCL-Sci  |e SHAP  |e CRERAR  |b 65019649  |i 7704983